References
- Vallon R, Freuler F, Desta-Tsedu N, Robeva A, Dawson J, Wenner P, Engelhardt P, Boes L, Schnyder J, Tschopp C, Urfer R, Baumann G. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J Immunol 2001; 166: 2801–2807
- Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Kelvin DJ, Oppenheim JJ. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of Mo and polymorphonuclear leukocytes. J Exp Med 1994; 180: 203–209
- Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008; 8: 349–361
- El Kebir D, Jozsef L, Filep JG. Opposing regulation of Nph apo through the formyl peptide receptor-like 1/lipoxin A4 receptor: Implications for resolution of inflammation. J Leukoc Biol 2008; 84: 600–606
- Yacoubian S, Serhan CN. New endogenous anti-inflammatory and proresolving lipid mediators: Implications for rheumatic diseases. Nat Clin Pract Rheumatol 2007; 3: 570–579
- Aliberti J, Serhan C, Sher A. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J Exp Med 2002; 196: 1253–1262
- van Zandbergen G, Hermann N, Laufs H, Solbach W, Laskay T. Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by Nph. Infect Immun 2002; 70: 4177–4184
- van Zandbergen G, Bollinger A, Wenzel A, Kamhawi S, Voll R, Klinger M, Muller A, Holscher C, Herrmann M, Sacks D, Solbach W, Laskay T. Leishmania disease development depends on the presence of apo promastigotes in the virulent inoculum. Proc Natl Acad Sci USA 2006; 103: 13837–13842
- Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR. Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apo Nph by MoMa. J Immunol 2000; 164: 1663–1667
- Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apo cells: Getting rid of the corpses. Mol Cell 2004; 14: 277–287
- Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apo cells. Nature 1997; 390: 350–351